10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ended September 30, 2025 after market close on Thursday, November 6, 2025. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company’s website prior to the conference call.

Live audio of the webcast will be available on the “Investors” section of the company website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world’s understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedInXFacebookBluesky or YouTube.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (https://www.10xgenomics.com/), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts 
Investors: investors@10xgenomics.com 
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-third-quarter-2025-financial-results-on-november-6-2025-302580145.html

SOURCE 10x Genomics, Inc.

Staff

Recent Posts

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

3 hours ago

Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic

ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD.USANewsGroup.com News Commentary VANCOUVER, BC, Jan. 16, 2026 /PRNewswire/…

4 hours ago

Equinox Integrates Oura Ring Data Into EQX ARC, New Women’s Health & Performance Program

NEW YORK, Jan. 16, 2026 /PRNewswire/ -- Equinox, the authority in high-performance luxury lifestyle, announced that…

4 hours ago

Patient Engagement Solutions Market worth $51.69 billion by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Jan. 16, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Patient Engagement Solutions Market…

4 hours ago

From Awareness to Action: Linus Health Drives the Next Era of Early Brain Health Detection

Expanding adoption, evidence, and innovation to support earlier identification and intervention across care and researchBOSTON,…

4 hours ago